SCHEMBL6359795

SCHEMBL6359795

CCc1n[c]c2c(-c3ccccc3)csc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 8/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 2/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 3/20 0.36
DAPK3 O43293 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
ABL1 P00519 1/20 0.35
NTRK1 P04629 1/20 0.35
LCK P06239 1/20 0.35
CSF1R P07333 1/20 0.35
RET P07949 1/20 0.35
MET P08581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6359338 0.83 ESR1 (0.38) ALDH1A1ALOX15MAPK1HSD17B10LMNA
SCHEMBL5790639 0.83 HTT (0.35) ALDH1A1ALOX15MAPK1HSD17B10LMNA
SCHEMBL6364115 0.78 HTT (0.41) ALDH1A1HSD17B10LMNASMN1; SMN2TSHR
SCHEMBL6364382 0.78 ESR1 (0.45) ALDH1A1MAPK1HSD17B10LMNASMN1; SMN2
SCHEMBL6362941 0.77 MAPT (0.38) ALDH1A1ALOX15MAPK1HSD17B10LMNA
SCHEMBL2368948 0.77 ALDH1A1 (0.38) ALDH1A1ALOX15MAPK1HSD17B10LMNA
SCHEMBL5789324 0.74 FGFR1 (0.35) ALDH1A1ALOX15MAPK1HSD17B10LMNA
SCHEMBL2368935 0.74 ALDH1A1 (0.44) ALDH1A1ALOX15MAPK1HSD17B10LMNA
SCHEMBL2369472 0.73 MEN1 (0.44) ALOX15HSD17B10GAAGSK3AGSK3B
SCHEMBL6359949 0.73 SQOR (0.37) ALDH1A1LMNASMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 ALDH1A1 247/4885ALOX15 1117/4885MAPK1 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.